EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Distinct Longitudinal Clinical‐Neuroanatomical Trajectories in Parkinson's Disease Clinical Subtypes: Insight toward Precision Medicine

Seyed-Mohammad Fereshtehnejad iD, Roqaie Moqadam, Houman Azizi, Ronald B Postuma iD, Mahsa Dadar, Anthony E Lang, Connie Marras, Yashar Zeighami iD

Movement Disorders · 2025-08 · 40 (8) · 1572-1583

DOI: 10.1002/mds.30229 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 26.05.2025. Verfasst von Seyed-Mohammad Fereshtehnejad und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurology, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada. Hauptthemen laut MEDLINE: Parkinson Disease, Precision Medicine, Brain. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fonds de Recherche du Québec - Santé, CIHR, Natural Sciences and Engineering Research Council of Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Parkinson's disease (PD) varies widely across individuals in clinical manifestations and course of progression. Identification of distinct biological subtypes could explain this heterogeneity, identify its pathophysiology, and predict disease progression.

Objectives

Our aim was to compare longitudinal clinical trajectories and brain atrophy patterns between clinical subtypes defined at the baseline de novo PD.

Methods

We analyzed data from 421 PD patients (mean follow‐up: 8.2 years) in the Parkinson's Progression Markers Initiative (PPMI). Using multi‐domain motor and non‐motor criteria, de novo patients were classified into “mild motor‐predominant” (n = 223), “intermediate” (n = 146), and “diffuse‐malignant” (n = 52) subtypes. Deformation‐based morphometry was performed on T1‐weighted magnetic resonance imaging (MRIs) from 128 PD patients with at least two MRIs (71 mild motor‐predominant, 42 intermediate, and 15 diffuse‐malignant) and 60 controls, with an average MRI follow‐up duration of 3.4 ± 1.1 in the PD cohort. Mixed‐effects models compared clinical progression and longitudinal pattern of regional atrophy across subtypes.

Results

The diffuse‐malignant subtype exhibited faster worsening of motor severity ( P = 0.007), cognition ( P < 0.0001), and activities of daily living ( P < 0.0001) compared to mild motor‐predominant subtype over 8 years. These findings remained statistically significant after an age‐matched subgroup analysis and adjustment for the levodopa treatment. Accelerated atrophy was observed in the precuneus, temporal and fusiform gyri, cerebellum, and other regions (corrected‐ P < 0.05).

Conclusions

Longitudinal analysis revealed distinct patterns of clinical progression and regional atrophy in PD subtypes, with the diffuse‐malignant subtype showing more severe neurodegeneration and clinical deterioration suggesting existence of diverse pathophysiological mechanisms in PD. © 2025 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseasePrecision MedicineBrainHumansMaleFemaleDisease ProgressionAgedMagnetic Resonance ImagingMiddle AgedLongitudinal StudiesAtrophy

Stichwörter der Autor:innen

Parkinson's diseasebased morphometrydeformationlongitudinalmagnetic resonance imagingsubtype

Autor:innen und Institutionen

  • Division of Neurology, Toronto Western Hospital, University of Toronto, Toronto, Ontario, Canada.
  • The Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, Ontario, Canada.
  • Department of Neurobiology, Care Sciences and Society (NVS), Karolinska Institute, Stockholm, Sweden.
  • Douglas Mental Health University Institute, Department of Psychiatry, McGill University, Montreal, Quebec, Canada.
  • Integrated Program in Neuroscience, McGill University, Montreal, Quebec, Canada.
  • Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada.

ORCID-Profile: Seyed-Mohammad Fereshtehnejad, Ronald B Postuma, Yashar Zeighami

Förderung

  • Fonds de Recherche du Québec - Santé
  • CIHR
  • Natural Sciences and Engineering Research Council of Canada
  • Healthy Brains Healthy Lives
  • Canadian Institutes of Health Research

Zitieren

APA

Fereshtehnejad, S. M., Moqadam, R., Azizi, H., Postuma, R. B., Dadar, M., Lang, A. E., Marras, C., & Zeighami, Y. (2025). Distinct Longitudinal Clinical‐Neuroanatomical Trajectories in Parkinson's Disease Clinical Subtypes: Insight toward Precision Medicine. Movement Disorders, 40(8), 1572-1583. https://doi.org/10.1002/mds.30229

Vancouver

Fereshtehnejad SM, Moqadam R, Azizi H, Postuma RB, Dadar M, Lang AE, et al. Distinct Longitudinal Clinical‐Neuroanatomical Trajectories in Parkinson's Disease Clinical Subtypes: Insight toward Precision Medicine. Movement Disorders. 2025;40(8):1572-1583. doi:10.1002/mds.30229

BibTeX
@article{Fereshtehnejad2025,
  author = {Fereshtehnejad, Seyed-Mohammad and Moqadam, Roqaie and Azizi, Houman and Postuma, Ronald B and Dadar, Mahsa and Lang, Anthony E and Marras, Connie and Zeighami, Yashar},
  title = {Distinct Longitudinal Clinical‐Neuroanatomical Trajectories in Parkinson's Disease Clinical Subtypes: Insight toward Precision Medicine},
  journal = {Movement Disorders},
  year = {2025},
  volume = {40},
  number = {8},
  pages = {1572--1583},
  doi = {10.1002/mds.30229}
}
Kostenlos starten →